The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-04), Hologic's share price is MXN1260.00. Hologic's Book Value per Share for the quarter that ended in Dec. 2025 was MXN423.38. Hence, Hologic's PB Ratio of today is 2.98.
The historical rank and industry rank for Hologic's PB Ratio or its related term are showing as below:
MEX:HOLX'
s PB Ratio Range Over the Past 10 Years
Min: 2.61 Med: 4.12 Max: 8.01
Current: 3.23
During the past 13 years, Hologic's highest PB Ratio was 8.01. The lowest was 2.61. And the median was 4.12.
MEX:HOLX's PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.09
vs MEX:HOLX: 3.23
During the past 12 months, Hologic's average Book Value Per Share Growth Rate was 11.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 13.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hologic was 274.80% per year. The lowest was -14.80% per year. And the median was 5.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hologic PB Ratio Related Terms
Hologic PB Ratio Historical Data
* Premium members only.
The historical data trend for Hologic's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hologic's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hologic's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Hologic's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hologic (MEX:HOLX) has a PB Ratio of 2.98 as of Jul. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hologic and its competitors. This is 28% below median its historical median of 4.12. Over the past decade, Hologic's PB Ratio has ranged from 2.61 to 8.01.
Is Hologic's PB Ratio too high?
Hologic's current PB Ratio of 2.98 is 28% below median its 10-year median of 4.12. Over the past 10 years, this metric has ranged from a low of 2.61 to a high of 8.01. The Medical Devices & Instruments industry median PB Ratio is 2.09. Hologic's value of 2.98 is 42.6% above this industry median. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's PB Ratio compare to WST and COO?
Hologic's PB Ratio of 2.98 can be compared against companies in the Medical Devices & Instruments industry. The industry median PB Ratio is 2.09. Hologic's value of 2.98 is 42.6% above this benchmark. Historically, Hologic's own PB Ratio has ranged from 2.61 to 8.01 over the past decade. While the company's 10-year median is 4.12 vs. the industry median of 2.09, Hologic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.09, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current PB Ratio of 2.98 is 42.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current PB Ratio is 2.98, which is 28% below median its own 10-year median of 4.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (MEX:HOLX) has a current PB Ratio of 2.98. The stock's GF Value™ is MXN1,360.12, compared to a current price of MXN1,260.00 — trading 7.4% below its estimated fair value. The current PB Ratio is 2.98, which is 28% below median its 10-year median of 4.12 and 42.6% above the Medical Devices & Instruments industry median of 2.09. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hologic (MEX:HOLX), the current PB Ratio is 2.98 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (MEX:HOLX) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of MXN1,260.00 is trading 7.4% below its estimated GF Value™ of MXN1,360.12.
Key valuation signals for MEX:HOLX:
PB Ratio: 2.98 (28% below median its 10-year median of 4.12)
GF Value™: MXN1,360.12 vs. price of MXN1,260.00 (7.4% below fair value)
Industry Position: 42.6% above the Medical Devices & Instruments median
No single metric tells the full story. See the MEX:HOLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for MEX:HOLX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HOLX has been successfully added to your 
